Filing Details
- Accession Number:
- 0001209191-23-050433
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-22 19:35:51
- Reporting Period:
- 2023-09-22
- Accepted Time:
- 2023-09-22 19:35:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1782223 | Pyxis Oncology Inc. | PYXS | Pharmaceutical Preparations (2834) | 831160910 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1941706 | Jitendra Wadhane | C/O Pyxis Oncology, Inc. 321 Harrison Avenue Boston MA 02118 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-22 | 2,500 | $1.74 | 219,437 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.7397 per share.
Billionaire Hedge Funds
